Diabetic macular edema is a complication that develops from diabetic retinopathy, a widespread consequence of diabetes and a ...

While Johnson & Johnson isn't the first to secure FDA approval for an FcRn-blocking antibody in myasthenia gravis, the New ...

TNX-1700 is in preclinical development for gastric and colorectal cancers ...

US Secretary of State Marco Rubio was in Paris on Thursday to meet French President Emmanuel Macron about crafting a Ukraine ceasefire, as Washington and Europe seek common ground on ending the ...

Following this, we optimized the in vitro bioconjugation process by adjusting the molar ratio of Scl2-ST to ELP-SC to 2:1, maximizing the yield of the fusion protein through the application of ...

WEDNESDAY, April 16, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved a self-injection version of Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) for the ...

WASHINGTON (AP) — U.S. researchers will soon test whether livers from a gene-edited pig could treat people with sudden liver failure — by temporarily filtering their blood so their own organ ...

We demonstrate that in contrast to VGLL2 and TEAD1, the fusion proteins are strong activators of TEAD-dependent transcription, and their function does not require YAP/TAZ. Furthermore, we identify ...

We demonstrate that, in contrast to VGLL2 and TEAD1, the fusion proteins are strong activators of TEAD-dependent transcription, and their function does not require YAP/TAZ. Furthermore, we identify ...

becoming the first standalone encryption solution to receive Authority to Operate (ATO) from the U.S. Food and Drug Administration (FDA) for use in life-critical medical and digital infrastructure.

from the U.S. Food and Drug Administration (FDA) for use in life-critical medical and digital infrastructure.

Full approval of Vitrakvi was based on results from three clinical trials in patients with unresectable or metastatic NTRK fusion-positive solid tumors. “This first full approval of an NTRK inhibitor ...